(Q37879172)

24 August 2017

1 reference

title

Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures (English)

1 reference

24 August 2017

Thomas A Albini

3

0 references

author name string

Zohar Yehoshua

series ordinal

1

1 reference

24 August 2017

Philip J Rosenfeld

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Seminars in Ophthalmology

24 August 2017

published in

1 reference

24 August 2017

volume

26

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

167-180

1 reference

Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Concordance of disease progression in bilateral geographic atrophy due to AMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Complement C3 variant and the risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Complement factor H polymorphism and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Smoking and age-related macular degeneration: a review of association.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Molecular pathology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The role of apoptosis in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Use of fundus imaging in quantification of age-related macular change

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Issues in quantifying atrophic macular disease using retinal autofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Automated detection of macular drusen using geometric background leveling and threshold selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Fundus autofluorescence imaging: review and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Simultaneous acquisition of sectional and fundus ophthalmic images with spectral-domain optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Pharmacologic treatment of atrophic age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Macular pigment and age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Lipofuscin of the retinal pigment epithelium: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Complement, age-related macular degeneration and a vision of the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Immunopathological aspects of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Drusen complement components C3a and C5a promote choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.577132

10.3109/08820538.2011.577132

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference